The Finnegan Moye Schatz McLaughlin Boyle Group IS supporting
The Iris Fund’s mission to end preterm birth and stillbirth.
The Iris Fund was founded in July 2017 after the Crystal-Aleman family suffered the devastating loss of their daughter Iris after an emergency C-section. Iris was just 28 weeks old.
Eight years later, The Iris Fund is the leading private funder of basic science research to determine the causes of preterm birth, working to help mothers and babies have safer and healthier pregnancies and deliveries. As a principal convenor and advocate for preterm babies and their families, The Iris Fund is determined to make certain no family endures heartbreaking complications and loss due to prematurity.
This Giving Season, we are supporting The Iris Fund as they continue their live-saving work.
Please join us.
The Iris Fund brings together leaders in research, clinical care and patient advocacy to change the trajectory of preterm birth for the next generation.
In everything we do, we insist on strong data to support the steps we take and ensure that the mother’s voice and experience is at the center of every decision.
Learn more about The Iris Fund here.